Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory Council
R. Kulkarni et al., Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory Council, HAEMOPHILIA, 5(6), 1999, pp. 410-415
We undertook this survey to determine institutional practices of obstetrici
ans, neonatologists and haematologists regarding care of pregnant haemophil
ia carriers and newborns with haemophilia and intracranial haemorrhage (ICH
). Our purpose was also to determine whether institutions had written guide
lines to manage such patients. Questionnaires were sent to 1000 obstetricia
ns and through the Haemophilia Treatment Centres (HTC) to 180 paediatric ha
ematologists and 180 neonatologists, each representing an institution.
Twenty-three per cent of obstetricians, 22% of neonatologists and 16% of pa
ediatric haematologists returned completed surveys. Over 94% of the respond
ents had no written guidelines for management of pregnant haemophilia carri
ers or their newborns or for neurologic assessment of newborns. For known h
aemophilia carriers, 57% of the obstetricians routinely preferred vaginal d
elivery and 11% preferred caesarean section. Availability of perinatal serv
ices influenced prenatal management (P < 0.05). In term newborns with docum
ented ICH, only 23% of neonatologists would evaluate for haemophilia, where
as in pre-term newborns with ICH, this number dropped even further to 3%. F
or all newborns with haemophilia, 40% preferred routine administration of c
lotting factor concentrates (CFC) immediately following birth to offset the
trauma of delivery and 89% of paediatric haematologists favoured early pro
phylaxis with CFC.
Guidelines are needed for management of pregnant haemophilia carriers as we
ll as newborns with haemophilia. Physicians need to be made aware that ICH
may be a presenting sign of haemophilia in both term as well as pre-term ne
wborns, so that appropriate therapy can be instituted early in the event of
a bleed.